Search
for
Sort by
Research 271–300 of 1000+
- Cutaneous lesions and clinical outcomes in five cats after frunevetmab injections
- 13 Complications of Platelet-Rich Plasma and MicroneedlingPlatelet-rich plasma (PRP)complications ofMicroneedlingcomplications of
- RASopathic Skin Eruptions during Vemurafenib Therapy
- The Impact of GLP-1 Receptor Agonists on Hair: Beneficial Effects or Adverse Outcomes?
- Angioedema After Squaric Acid Treatment in a 6‐Year‐Old Girl
- Oral Diseases During Systemic Psoriatic Drugs: A Review of the Literature and Case Series
- Anti-TNF-Alpha Induced Psoriasiform Eruptions with Severe Scalp Involvement and Alopecia: Report of Five Cases and Review of the Literature
- Patient satisfaction and adverse effects following the use of topical hair fiber fillers
- Alopecia as an Emerging Adverse Effect Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss: A Scoping Review
- The Therapeutic Use of Topical Minoxidil
- Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients
- Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management
- A Prospective Self-controlled Clinical Trial of Nonactivated Low Leukocyte PRP in Female Pattern Hair Loss Patients of Childbearing Age
- Commentary
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Eccema dishidrótico palmoplantar asociado a secukinumab
- Erosive pustular dermatosis of the scalp induced by gefitinib: case and review of the literature
- Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases
- Cyclosporine-induced alopecia:a case report, FDA adverse event reporting system analysis and literature assessment
- Successful treatment of alopecia universalis with abrocitinib: a case report
- Retrospective analysis of smell and taste disturbances associated with dermatologic medications reported to the United States Food and Drug Administration and relevance to COVID-19 infections
- Alfatradiol (0,025 %) - Eine wirksame und sichere Therapieoption zur Behandlung der androgenetischen Alopezie bei Frauen und Männern
- Morphea‐like lesion following topical endectocide application in a cat
- Study on botulinum toxin in dermatology from 2000 to 2023: A CiteSpace‐based bibliometric analyses
- A Case of Inflammatory Nonscarring Alopecia Associated With the Tyrosine Kinase Inhibitor Nilotinib
- 51794 Compounded Solution to Personalize Alopecia Management
- Sorafenib-Induced Pityriasis Rubra Pilaris-like Eruption: A Case Report
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Systematic review of low-level laser therapy for adult androgenic alopecia
- The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients